Skip to main content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
BMC Oral Health. 2022; 22: 204.
Published online 2022 May 25. doi: 10.1186/s12903-022-02238-7
PMCID: PMC9131687
PMID: 35614416

Unplanned reoperation after radical surgery for oral cancer: an analysis of risk factors and outcomes

Associated Data

Data Availability Statement

Abstract

Background

Unplanned reoperation (UR) after radical surgery for oral cancer (OC) is a health threat for the patients. The aim of the study was to identify the incidence of and risk factors for unplanned reoperation following oral cancer radical surgery, and to explore a potential role for long-term survival.

Methods

The present study followed a retrospective study design. Univariate and multivariate analyses were used to identify risk factors for demographic and clinical characteristics of patients. Survival analysis was performed by the Kaplan–Meier method. The data was analyzed statistically between November and December 2021.

Results

The incidence of UR was 15.7%. The primary cause of UR was reconstructed flap complications. Multivariate logistic regression analyses revealed that diabetes, tumor size, type of reconstruction, and nodal metastasis were independent risk factors for UR. Patients undergoing UR had a longer hospitalization, more post-operative complications, and a higher mortality compared with the non-UR group. UR is negatively correlated with the cancer-specific survival rate of patients (Log-rank test, P = 0.024).

Conclusion

Diabetes, tumor size, pedicled flap reconstruction and cervical nodal metastasis (N2) as independent risk factors for UR was discovered. UR was positively correlated with perioperative complications prolong hospital stay, and increased early mortality, but negatively correlated with the cancer-specific survival rate survival rate.

Keywords: Reoperation, Risk factors, Treatment outcome, Survival analysis

Background

Oral cancer (OC) ranks as the sixth most common carcinoma, and it’s a matter of global concern [1]. The higher prevalence and mortality of oral cancer have been reported in developing countries, and China has been perceived as a high incidence of oral cancer [1, 2]. Rapid diagnosis can better control the transformation of precancerous lesions to oral cancer, and improve the overall survival rate of patients [3]. Along with technological developments, tissue fluorescence imaging and molecular biomarkers are used extensively in the cancer clinic [3, 4]. While these technologies have attractive advantages, they all have disadvantages. For example, the characteristics of false-positive, insufficient diagnostic ability, and the clinical diagnostic ability have not been recognized internationally. Therefore, histopathological examination currently remains the diagnostic gold standard. Surgery is considered to be the most effective modalities for the treatment of oral cancer patients [5]. Despite continuing improvements in surgical methods, reducing the complications and improving long-term survival remains a concern. Due to the intricacy of the surgery, postoperative 30-day complication rates for oral cancer can be as high as 20.3% [6]. Approximately 10% of patients with these complications require reoperation [6].

In the perioperative period, patients with surgical complications may undergo unplanned reoperation. Unplanned reoperations have been extensively researched in a variety of surgical fields [710]. Previous studies have established that unplanned reoperation or readmission may be associated with colorectal cancer and brain tumor recurrence and mortality [11, 12]. Unplanned reoperations are not expected by surgeons and patients, which will bring physical and psychological pressure to patients, increase hospitalization costs, and put pressure on social resources [13]. Unplanned reoperations account for between 2 and 10% of all surgeries in most surgical areas [1417]. Several studies examined the risk factors of unplanned reoperation for head and neck cancer surgery complications. Choi et al. showed that long operation time, previous treatment, and higher N (N2) classification were considered key risk factors for unplanned reoperation [18]. According to Zhao et al.’s study, the leading cause of UR were postoperative bleeding, vascular crisis, and diagnostic issues, and patients with microvascular flaps or malignant tumors [19]. Up to now, far too little attention has been paid to assessing the incidence and risk factors associated with UR for oral cancer. To our knowledge, no previous study has given sufficient consideration to the impact of UR on long-term survival after radical oral cancer surgery. Thus, there is a great need to understand the relationship between UR and cancer prognosis.

The aim of the study was to identify the incidence of and risk factors for unplanned reoperation following oral cancer radical surgery, and to explore a potential role for long-term survival. The result from the study may increase the attention of UR among clinicians and reduce the incidences of postoperative complications after surgery.

Methods

Materials and methods

A retrospective analysis was done on oral cancer patients treated with radical oral cancer surgery in the Department of Oral and Maxillofacial Surgery, The Affiliated Huaian No.1 People’s Hospital of Nanjing Medical University. 506 patients undergoing radical surgery for OC between February 2014 and November 2019 were included. The exclusion criteria were as follows: (1) maxillofacial salivary cancer patients, leaving oral cavity cancer patients (n = 30); (2) patients who did not receive neck dissection (n = 27); (3) patients who received radiotherapy and chemotherapy before surgery (n = 28). Together, 421 patients were enrolled for further analysis. According to postoperative assessment, 66 patients were assigned to the UR group, and 355 patients were termed the non-UR group (Fig. 1). All patients were followed for up to 2 years. We strictly followed 1975 Declaration of Helsinki ethical guidelines. This study was approved by the ethical review board of The Affiliated Huaian No.1 People’s Hospital of Nanjing Medical University.

An external file that holds a picture, illustration, etc.
Object name is 12903_2022_2238_Fig1_HTML.jpg

Flowchart of patient selection. UR, unplanned reoperation

Data collection and definitions

Basic information on patients, body mass index (BMI), medical history, surgical procedures, postoperative complications, and the annual follow-up data were derived from the medical record database of The Affiliated Huaian No.1 People’s Hospital of Nanjing Medical University. OC was diagnosed according to histopathological evaluation, and the histological grade was staged according to the AJCC-TNM staging [20]. UR refers to the status that the occurrence of re-operation and retreatment follow-up 30 days after surgery due to complications caused by oral cancer surgery. The cancer survival rate was defined as the time from the first day of treatment performed to death.

Operative techniques

Experienced surgeons perform all operations in oral and maxillofacial surgery at our center. At least 50 radical surgeries for oral cancer have been performed by surgeons. The operation method was decided using a risk-adapted approach based on tumor location and size, according to the treatment principle for oral cancer [21, 22]. Free or pedicled flaps were adopted for large postoperative defects' reconstruction after surgery: submental island flap, forearm flap, fibula flap, and anterolateral thigh flap.

Follow-up

A flow chart presenting patient selection is displayed in Fig. 1. Follow-up data were collected from all patients who survived the UR procedure (n = 66), and 355 patients in the non-UR group. Telephone follow-up, medical records, visiting, or outpatient/inpatient clinic visits were used to collect follow-up data. The deadline for follow-up was December 31, 2021.

Statistical analysis

Univariable and multivariable analysis were used to evaluate clinical factors for unplanned reoperation. Categorical data were analyzed by Chi-square test or Fisher’s exact test. Continuous data were compared with the Mann–Whitney U test. A multivariate Cox regression analysis and Kaplan–Meier analysis were utilized to assess recurrence-free and overall survival of UR. All data analyses were performed with the SPSS (IBM SPSS 22.0, SPSS Inc). Statistical tests were two sided and considered significant with a P-value < 0.05.

Results

Clinical variables between UR group and non-UR group

421 patients were enrolled in the study, included 227 males and 194 females. The mean age was 65.0 ± 8.0 years, 66cases (mean age: 71.1 ± 10.1 years) underwent UR, including 41 males and 25 females. The incidence of UR was 15.7% (66/421). The leading cause of unplanned reoperation was reconstruction flap related complications (32/66, 48.5%), followed by bleeding (9/66, 13.6%), necrosis (7/66, 10.6%), infection (6/66, 9.1%), fistula (2/66, 3.0%), and flap donor site complications (2/66, 3.0%) (Table (Table1).1). Gender, age, smoking, drinking, BMI, preoperative anemia, tumor size and cervical node metastasis did not show a significant difference in UR group and non-UR group. Early tumor (T1-T2) and no lymph node metastases (N0) were the most common cancer types in the UR group (86.4% and 75.8%, respectively) and the non-UR group (88.2% and 83.4%, respectively) (Table (Table22).

Table 1

Causes of UR within 30 days in oral cancer surgery (n = 66)

CausesNo. (%)
Reconstructed flap complications32(48.5)
Bleeding9 (13.6)
Necrosis7 (10.6)
Infection6 (9.1)
Fistula2 (3.0)
Flap donor site complications2 (3.0)
Others8 (12.2)

UR, unplanned reoperation

Table 2

Univariate analysis of potential influencing factors for UR

VariablesNon-URURP-value
Group (n, %)Group (n, %)
Gender0.1786
 Male186 (52.4)41 (62.1)
 Female169 (47.6)25 (37.9)
Age0.7737
 < 60111 (31.3)22 (33.3)
 ≥ 60244 (68.7)44 (66.7)
Smoking0.6661
 No318 (89.6)58 (87.9)
 Yes37 (10.4)8 (12.1)
Alcohol0.6232
 No328 (92.4)60 (90.9)
 Yes27 (7.6)6 (9.1)
BMI (kg/m2)0.5823
 ≤ 25215 (60.6)43 (65.2)
 > 25140 (39.4)23 (34.8)
Hypertension0.0367*
 No262 (73.8)40 (60.6)
 Yes93 (26.2)26 (39.4)
Diabetes0.0128*
 No318 (89.6)51 (77.3)
 Yes37 (10.4)15 (22.7)
Preoperative anemia
 No292 (82.3)54 (81.8) > 0.9999
 Yes63 (17.7)12 (18.2)
Tumor size0.6821
 T1–T231357
 T3–T4429
Cervical node metastasis0.2457
 N0296 (83.4)50 (75.8)
 N135 (9.6)11 (16.7)
 N224(7.0)5 (7.5)
Type of reconstruction0.0002*
 Local flap283 (79.7)37 (56.1)
 Pedicled flap38 (10.7)17 (25.8)
 Free flap34 (9.6)12 (18.1)
Cancer subsites0.0390*
 Oral cavity30461
 Oropharynx94
 Larynx70
 Salivary Gland351

*P < 0.05

UR, unplanned reoperation; BMI, body mass index

Furthermore, the multivariate analysis showed that diabetes (OR = 2.544, 95%CI 1.257–5.128, P = 0.009), tumor size (OR = 1.879, 95%CI 1.038–3.401, P = 0.037), N classification (N2, OR = 3.076, 95%CI 1.526–6.211, P = 0.002) and type of reconstruction (pedicled flap reconstruction, OR = 0.491, 95%CI 0.259–0.931, P = 0.029) were independent risk factors for unplanned reoperation in OC patients (Table (Table33).

Table 3

Multivariate analysis of potential influencing factors for UR

VariableMultivariate survival analysis
Hazard ratio95% CIp-value
Gender0.9970.616–1.6130.991
Smoking1.1800.424–3.2860.751
Alcohol use0.7220.242–2.1540.559
BMI (kg/m2)1.2820.751–2.1890.362
Hypertension1.5190.792–2.9140.208
Age0.5500.036–8.3850.667
Diabetes2.5441.257–5.1280.009*
Preoperative anemia0.6430.374–1.1040.109
Tumor size1.8791.038–3.4010.037*
Cervical nodal metastasis
 N0
 N12.2770.918–5.6490.076
 N23.0761.526–6.2110.002*
Type of reconstruction
 Local flapRef
 Pedicled flap0.4910.259–0.9310.029*
 Free flap0.3990.151–1.0550.064
Cancer subsites
 Oral cavityRef
 Oropharynx0.5910.059–5.9270.655
 Salivary gland0.7380.780–7.0040.791

Numbers in boldface indicate statistically significant values (P < 0.05)

*P < 0.05

UR, unplanned reoperation; BMI, body mass index

Early surgical outcomes of the UR patients

The incidence of postoperative complications after surgery were 77.3% (51/66) in UR group while the incidence for non-UR group was 6.5% (23/355), including reconstructed flap complications, infection, bleeding, fistula, flap donor site complication and necrosis. Additionally, lengths of stay in the UR group had a significantly increased compared with the non-UR group (23.78 ± 0.82 vs 13.24 ± 0.32 days, P < 0.001) (Table (Table44).

Table 4

Early surgical outcomes for patients with or without UR

ParametersNon-UR group
(n = 355)
UR group
(n = 66)
P-value
Hospital stay (days)13.24 ± 0.3223.78 ± 0.82 < 0.001*
Postoperative complications23(6.5%).a51(77.3%).b< 0.001*
Mortality rate0(0.0%).a2(3.0%).b0.024*

*P < 0.05

aParameters in the non-UR group refer to data after the initial operation

bParameters in the UR group refer to data after the second operation

UR, unplanned reoperation

UR as a prognostic factor for long-term survival

In the survival analysis of OC patient prognosis, the mean follow-up time was 53 months. According to the univariate survival analyses, unplanned reoperation, type of reconstruction, age, diabetes, preoperative anemia, tumor size, and cervical nodal metastasis may be predictive factors for recurrence-free survival (Table (Table5).5). Furthermore, the results of multivariate logistic regression analysis showed that age (HR = 3.077, 95%CI 1.664–5.682, P < 0.01), diabetes (HR = 1.833, 95%CI 1.091–3.257, P = 0.02), N classification (N1, HR = 4.464, 95%CI 2.551–7.813, P < 0.01) (N2, HR = 2.315, 95%CI 1.101–4.878, P = 0.03), type of reconstruction (Pedicled flap, HR = 0.413, 95%CI 0.236–0.722, P = 0.02) (free flap, HR = 0.354, 95%CI 0.148–0.801, P = 0.01), and unplanned reoperation (HR = 2.864, 95%CI 1.181–7.401, P = 0.02) were independent predictors of outcome (Table (Table5).5). UR was significantly associated with shortened cancer-specific survival in this study (Log-rank test, P = 0.024) (Fig. 2).

Table 5

Prognostic factors for cancer-specific survival after curative oral cancer resection in univariate and multivariable analyses

VariableUnivariate survival analysisMultivariate survival analysis
Hazard ratio95% CIp-valueHazard ratio95% CIp-value
Gender0.9870.633–1.5410.955
Smoking0.9270.446–1.9270.838
Alcohol use0.9500.413–2.1860.904
BMI (kg/m2)0.6510.400–1.0600.084
Hypertension1.2630.780–2.0470.342
Age2.3121.297–4.1230.005*3.0771.664–5.682 < 0.001*
Diabetes2.6931.583–4.582 < 0.001*1.8331.091–3.2570.023*
Preoperative anemia2.0061.246–3.2290.004*0.6780.415–1.1090.121
Tumor size2.0741.257–3.4210.004*0.6380.379–1.0740.091
Cervical nodal metastasis
 N0Ref
 N14.8782.873–8.264 < 0.001*4.4642.551–7.813 < 0.001*
 N22.6671.300–5.4640.007*2.3151.101–4.8780.027*
Type of reconstruction
 Local flapRef
 Pedicled flap0.4330.257–0.7290.002*0.4130.236–0.7220.002*
 Free flap0.3360.148–0.7630.009*0.3450.148–0.8010.013*
Cancer subsites
 Oral cavityRef
 Oropharynx1.6580.605–4.5450.325
 Larynx1.3900.254–7.5900.704
 Salivary Gland1.0410.116–9.3500.971
URO2.7681.118–6.8540.028*2.8641.181–7.4010.020*

Numbers in boldface indicate statistically significant values (P < 0.05)

*P < 0.05

UR, unplanned reoperation; BMI, body mass index

An external file that holds a picture, illustration, etc.
Object name is 12903_2022_2238_Fig2_HTML.jpg

Kaplan–Meier curves for cancer-specific survival. UR, unplanned reoperation

Discussion

The incidence of oral cancer is increasing year by year, which has become a global concern [23]. The sooner OC is diagnosed, the better the therapeutic efficacy was detected. The fluorescence method is a non-invasive way of diagnosing oral cancer, but it is still in clinical exploration due to the occurrence of false positives [24]. Histopathological examination currently remains the diagnostic gold standard. At present, physicians and scholars are devoted to the study of oral prognosis, but it is affected by many factors [25]. In recent years, UR is garnering more and more attention.

Over the last dozen years, the incidence of UR has decreased with the advances in surgical technique. Nevertheless, the poor prognosis among patients with UR remains a serious threat to global health. UR often is associated with higher postoperative morbidity, mortality and consequent high medical costs [26, 27]. In the current medical and health institutions, the UR rates was recognized as one of the evaluation indicators of surgical quality, attracting the attention of clinicians [8]. According to Choi et al.’s study, the incidence of unplanned reoperation in head and neck cancer surgery was 10.5% [18]. Zhao et al. reported that the overall unplanned reoperation rate in oral and maxillofacial surgery was 1.52% [19]. The incidence of UR was found to be 15.7 percent in this study, which enrolled over 400 patients. UR is typically correlated with complex surgical procedures such as radical surgery of oral cancer. To further lower risk factors and indications for UR, it is meaningful for surgeons to understand preoperative, perioperative, and postoperative risk factors. Meanwhile, we found that diabetes, tumor size, N classification (N2), and pedicled flap reconstruction were independent risk factors for UR.

Flap failure was the most dominant cause of unplanned reoperations in our study. Thomas’s comparative study showed a reoperation rate of 20.2% in the head and neck free flap reconstructions [28]. Recently, Kwok and Agarwal had investigated the reoperation rate of all microvascular free tissue transfers, and showed the overall reoperation rate was 12.9% and a head and neck reoperation rate was 18.0% [29]. Blockage of blood arteries owing to thrombus development was discovered to be a major cause of flap failure [30]. Anastomosis of a secondary vein has been proven beneficial to the survival of the flap and reduces venous congestion [30]. However, microscopic vascular anastomoses required enormous amounts of time to expend. Moreover, multiple studies showed that a single venous anastomosis can provide enough drainage while maintaining flap survival and reducing operation time, with no significant difference compared to two venous anastomosis [31, 32]. To prevent venous thrombosis, Matti Sievert et al. suggested that low molecular weight heparin can effectively improve the survival rate of the flap [33]. The above literature showed that one venous anastomosis combined with low molecular weight heparin applied could be attributed to an increased survival rate of flap.

Previous studies have found that postoperative bleeding is the most common reason for unplanned reoperation for a variety of diseases, including maxillofacial surgery [17, 34, 35]. Our data revealed that postoperative bleeding was the second most common complication after radical oral cancer surgery. There were only 9 cases of postoperative hemorrhage in UR group, accounting for nearly 13.6 percent of the total number of UR patients. Early postoperative bleeding is associated with hemostasis failure or coagulation defects [19]. Taking NSAIDS and hypertension together is a common cause of postoperative bleeding [36, 37]. In our opinion, preoperative coagulopathy should be given particular attention, and blood pressure should be maintained normal in individuals. Moreover, controlling hemostasis and blood pressure under anesthesia is critical intraoperatively [38]. In this study, delayed hemorrhages were more common in tiny arteries and muscle or connective tissue in the surgical area. To prevent hemostasis, an electrical knife has been widely used in a variety of surgical specialties. Zhao et al. considered that the postoperative bleeding was caused by inappropriate use of the electrical knife [19]. Electrical knives with a high frequency should stay in the tissue for a long enough time to establish effective hemostasis. The ultrasonic scalpel can be effective for providing a relative bloodless field in muscle or connective tissue, which facilitates saving surgical time [39]. Persistent postoperative pain promotes high blood pressure, which also leads to arrhythmia or small blood vessel hemorrhage. Sufficient postoperative analgesia is more conducive to reducing the risk of UR.

Marra et al. found that extra-nodal extension and perineural invasion are prognostic factors associated with reduced disease-free survival for oral tongue cancer [40]. Hussain et al. showed that nodal stage was the most important poor prognostic factor in terms of disease-free survival in T1, T2 oral tongue cancer [41]. Our research showed that UR may have a significant impact on oral cancer patients' long-term survival rates following surgery. In addition, multivariate analyses revealed that unplanned reoperation may be poor prognostic factors for cancer-specific survival.

Despite our efforts to subject it to a comprehensive analysis, the present study still has a few limitations. First, our study was based on retrospective single-center study. Further prospective multicenter studies may be warranted to further validate the findings. Second, the relatively small sample size of UR should be taken into consideration. Third, due to the complex condition of patients, different clinical decision-making for the same disease might affect our results. Therefore, a more comprehensive investigation is needed for further confirmation in the context of big data. Despite these limitations, the research confirmed the clinical importance of an unplanned reoperation in oral cancer surgery.

Conclusion

This study suggests that tumor size, diabetes, N classification (N2), and pedicled flap reconstruction might be risk factors for UR after oral cancer radical surgery. UR was associated with worse long-term survival, and may be a novel prognostic factor for OC patients. These findings may help identify high-risk patients for UR, optimize surgical planning, strengthen perioperative management, and reduce the incidence of unplanned reoperations.

Acknowledgements

The authors thank all the volunteers for participating in the study.

Abbreviations

URUnplanned reoperation
OCOral cancer
BMIBody mass index

Author contributions

MW conceived the study, carried out the design and coordination, wrote the manuscript, and gave the final approval of the version to be submitted. PY and HZ critically revised the manuscript for important intellectual content. WZ and PY collected the clinical data and drafted the article. All authors read and approved the final manuscript.

Funding

This study did not receive any funding and there are no financial conflicts of interest.

Availability of data and materials

The data are available from the corresponding author on reasonable request.

Declarations

Ethics approval and consent to participate

All participants gave written informed consent. This study was conducted according to the Declaration of Helsinki and was approved by the Institutional Ethics Committee of the Affiliated Huaian No.1 People’s Hospital of Nanjing Medical University.

Consent to publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Wei Zhang and Hong Zhu have contributed equally to this study.

Contributor Information

Wei Zhang, moc.361@04068605951m.

Hong Zhu, moc.361@gnohuhzyyah.

Pu Ye, moc.361@260774678py.

Meng Wu, nc.ude.umjn@mwyyah.

References

1. Warnakulasuriya S. Living with oral cancer: epidemiology with particular reference to prevalence and life-style changes that influence survival. Oral Oncol. 2010;46(6):407–410. doi: 10.1016/j.oraloncology.2010.02.015. [PubMed] [CrossRef] [Google Scholar]
2. Shrestha AD, Vedsted P, Kallestrup P, Neupane D. Prevalence and incidence of oral cancer in low- and middle-income countries: a scoping review. Eur J Cancer Care (Engl) 2020;29(2):e13207. doi: 10.1111/ecc.13207. [PubMed] [CrossRef] [Google Scholar]
3. Cervino G, Fiorillo L, Herford AS, Romeo U, Bianchi A, Crimi S, D'Amico C, De Stefano R, Troiano G, Santoro R, et al. Molecular biomarkers related to oral carcinoma: clinical trial outcome evaluation in a literature review. Dis Markers. 2019;2019:8040361. doi: 10.1155/2019/8040361. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
4. Cicciù M, Herford AS, Cervino G, Troiano G, Lauritano F, Laino L. Tissue fluorescence imaging (VELscope) for quick non-invasive diagnosis in oral pathology. J Craniofac Surg. 2017;28(2):e112–e115. doi: 10.1097/SCS.0000000000003210. [PubMed] [CrossRef] [Google Scholar]
5. Wong T, Wiesenfeld D. Oral cancer. Aust Dent J. 2018;63(Suppl 1):S91–S99. doi: 10.1111/adj.12594. [PubMed] [CrossRef] [Google Scholar]
6. Schwam ZG, Sosa JA, Roman S, Judson BL. Complications and mortality following surgery for oral cavity cancer: analysis of 408 cases. Laryngoscope. 2015;125(8):1869–1873. doi: 10.1002/lary.25328. [PubMed] [CrossRef] [Google Scholar]
7. Zuo X, Cai J, Chen Z, Zhang Y, Wu J, Wu L, Wang J. Unplanned reoperation after radical gastrectomy for gastric cancer: causes, risk factors, and long-term prognostic influence. Ther Clin Risk Manag. 2018;14:965–972. doi: 10.2147/TCRM.S164929. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
8. Sangal NR, Nishimori K, Zhao E, Siddiqui SH, Baredes S, Chan Woo Park R. Understanding risk factors associated with unplanned reoperation in major head and neck surgery . JAMA Otolaryngol Head Neck Surgery. 2018;144(11):1044–1051. doi: 10.1001/jamaoto.2018.2049. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
9. Program of Randomized Trials to Evaluate Pre-operative Antiseptic Skin Solutions in Orthopaedic Trauma I. Slobogean GP, Sprague S, Wells J, Bhandari M, Rojas A, Garibaldi A, Wood A, Howe A, Harris AD, et al. Effectiveness of iodophor vs chlorhexidine solutions for surgical site infections and unplanned reoperations for patients who underwent fracture repair: the PREP-IT master protocol. JAMA Netw Open. 2020;3(4):e202215. doi: 10.1001/jamanetworkopen.2020.2215. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
10. Kazaure HS, Chandra V, Mell MW. Unplanned reoperations after vascular surgery. J Vasc Surg. 2016;63(3):730–736. doi: 10.1016/j.jvs.2015.09.046. [PubMed] [CrossRef] [Google Scholar]
11. Mirnezami A, Mirnezami R, Chandrakumaran K, Sasapu K, Sagar P, Finan P. Increased local recurrence and reduced survival from colorectal cancer following anastomotic leak: systematic review and meta-analysis. Ann Surg. 2011;253(5):890–899. doi: 10.1097/SLA.0b013e3182128929. [PubMed] [CrossRef] [Google Scholar]
12. Dickinson H, Carico C, Nuño M, Mukherjee D, Ortega A, Black KL, Patil CG. Unplanned readmissions and survival following brain tumor surgery. J Neurosurg. 2015;122(1):61–68. doi: 10.3171/2014.8.JNS1498. [PubMed] [CrossRef] [Google Scholar]
13. Morris AM, Baldwin LM, Matthews B, Dominitz JA, Barlow WE, Dobie SA, Billingsley KG. Reoperation as a quality indicator in colorectal surgery: a population-based analysis. Ann Surg. 2007;245(1):73–79. doi: 10.1097/01.sla.0000231797.37743.9f. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
14. Mukerji N, Jenkins A, Nicholson C, Mitchell P. Unplanned reoperation rates in pediatric neurosurgery: a single center experience and proposed use as a quality indicator. J Neurosurg Pediatr. 2012;9(6):665–669. doi: 10.3171/2012.2.PEDS11305. [PubMed] [CrossRef] [Google Scholar]
15. McSorley S, Lowndes C, Sharma P, Macdonald A. Unplanned reoperation within 30 days of surgery for colorectal cancer in NHS Lanarkshire. Colorectal Dis. 2013;15(6):689–694. doi: 10.1111/codi.12135. [PubMed] [CrossRef] [Google Scholar]
16. Li Z, Shen J, Qiu G, Yu H, Wang Y, Zhang J, Zhao H, Zhao Y, Li S, Weng X, et al. Unplanned reoperation within 30 days of fusion surgery for spinal deformity. PLoS ONE. 2014;9(3):e87172. doi: 10.1371/journal.pone.0087172. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
17. Lyu HG, Sharma G, Brovman EY, Ejiofor J, Urman RD, Gold JS, Whang EE. Unplanned reoperation after hepatectomy: an analysis of risk factors and outcomes. HPB (Oxford) 2018;20(7):591–596. doi: 10.1016/j.hpb.2017.12.006. [PubMed] [CrossRef] [Google Scholar]
18. Choi N, Park SI, Kim H, Sohn I, Jeong HS. The impact of unplanned reoperations in head and neck cancer surgery on survival. Oral Oncol. 2018;83:38–45. doi: 10.1016/j.oraloncology.2018.06.004. [PubMed] [CrossRef] [Google Scholar]
19. Zhao Z, Hao J, He Q, Deng R. Unplanned reoperations in oral and maxillofacial surgery. J Oral Maxillofac Surg. 2019;77(1):135131–135135. doi: 10.1016/j.joms.2018.08.017. [PubMed] [CrossRef] [Google Scholar]
20. Huang SH, O'Sullivan B. Overview of the 8th edition TNM classification for head and neck cancer. Curr Treat Options Oncol. 2017;18(7):40. doi: 10.1007/s11864-017-0484-y. [PubMed] [CrossRef] [Google Scholar]
21. Bulsara VM, Worthington HV, Glenny A-M, Clarkson JE, Conway DI, Macluskey M. Interventions for the treatment of oral and oropharyngeal cancers: surgical treatment. Cochrane Database Syst Rev. 2018;12:CD006205. [PMC free article] [PubMed] [Google Scholar]
22. Kerawala C, Roques T, Jeannon JP, Bisase B. Oral cavity and lip cancer: United Kingdom National multidisciplinary guidelines. J Laryngol Otol. 2016;130(S2):S83–S89. doi: 10.1017/S0022215116000499. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
23. D’Souza S, Addepalli V. Preventive measures in oral cancer: an overview. Biomed Pharmacother. 2018;107:72–80. doi: 10.1016/j.biopha.2018.07.114. [PubMed] [CrossRef] [Google Scholar]
24. Cicciù M, Cervino G, Fiorillo L, D'Amico C, Oteri G, Troiano G, Zhurakivska K, Lo Muzio L, Herford AS, Crimi S et al. Early diagnosis on oral and potentially oral malignant lesions: a systematic review on the VELscope(®) fluorescence method. Dentistry J. 2019;7(3). [PMC free article] [PubMed]
25. Russo D, Mariani P, Caponio VCA, Lo Russo L, Fiorillo L, Zhurakivska K, Lo Muzio L, Laino L, Troiano G. Development and validation of prognostic models for oral squamous cell carcinoma: a systematic review and appraisal of the literature. Cancers. 2021;13(22) [PMC free article] [PubMed]
26. Palmer SJ, Parker MJ, Hollingworth W. The cost and implications of reoperation after surgery for fracture of the hip. J Bone Joint Surg Br. 2000;82(6):864–866. doi: 10.1302/0301-620X.82B6.0820864. [PubMed] [CrossRef] [Google Scholar]
27. Kroon HM, Breslau PJ, Lardenoye JWHP. Can the incidence of unplanned reoperations be used as an indicator of quality of care in surgery? Am J Med Qual. 2007;22(3):198–202. doi: 10.1177/1062860607300652. [PubMed] [CrossRef] [Google Scholar]
28. Thomas WW, Brant J, Chen J, Coblens O, Fischer JP, Newman JG, Chalian AA, Shanti RM, Cannady SB. Clinical factors associated with reoperation and prolonged length of stay in free tissue transfer to oncologic head and neck defects. JAMA Facial Plast Surg. 2018;20(2):154–159. doi: 10.1001/jamafacial.2017.1771. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
29. Kwok AC, Agarwal JP. Unplanned reoperations after microvascular free tissue transfer: an analysis of 2,244 patients using the american college of surgeons national surgical quality improvement program database. Microsurgery. 2017;37(3):184–189. doi: 10.1002/micr.22455. [PubMed] [CrossRef] [Google Scholar]
30. Ahmadi I, Herle P, Rozen WM, Leong J. One versus two venous anastomoses in microsurgical free flaps: a meta-analysis. J Reconstr Microsurg. 2014;30(6):413–418. doi: 10.1055/s-0034-1372368. [PubMed] [CrossRef] [Google Scholar]
31. Futran ND, Stack BC., Jr Single versus dual venous drainage of the radial forearm free flap. Am J Otolaryngol. 1996;17(2):112–117. doi: 10.1016/S0196-0709(96)90006-X. [PubMed] [CrossRef] [Google Scholar]
32. Dodd SX, Morzycki A, Nickel KJ, Campbell S, Guilfoyle R. One or two venous pedicles by anastomoses for free flaps in reconstruction of the lower extremity: a systematic review and meta-analysis. Microsurgery. 2021;41(8):792–801. doi: 10.1002/micr.30811. [PubMed] [CrossRef] [Google Scholar]
33. Sievert M, Goncalves M, Tamse R, Mueller SK, Koch M, Gostian AO, Iro H, Scherl C. Postoperative management of antithrombotic medication in microvascular head and neck reconstruction: a comparative analysis of unfractionated and low-molecular-weight heparin. Eur Archiv Oto-Rhino-Laryngol. 2021;278(5):1567–1575. doi: 10.1007/s00405-020-06219-w. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
34. Gangl O, Fröschl U, Hofer W, Huber J, Sautner T, Függer R. Unplanned reoperation and reintervention after pancreatic resections: an analysis of risk factors. World J Surg. 2011;35(10):2306–2314. doi: 10.1007/s00268-011-1213-5. [PubMed] [CrossRef] [Google Scholar]
35. Yang Y, Ma J, Lin Y, Wu X, Wang L, Wang A. Causes and affecting factors of unplanned reoperations in cancer patients. Zhonghua Zhong Liu Za Zhi. 2014;36(7):546–548. [PubMed] [Google Scholar]
36. Li P, Luo R, Guo L, Li W, Qi J. Impact of the body mass index on hemorrhage after surgery for thyroid cancer. Cancer Manag Res. 2020;12:557–565. doi: 10.2147/CMAR.S239264. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
37. Ono S, Kato M, Imai A, Yoshida T, Hirota J, Hata T, Takagi K, Kamada G, Ono Y, Nakagawa M, et al. Preliminary trial of rebamipide for prevention of low-dose aspirin-induced gastric injury in healthy subjects: a randomized, double-blind, placebo-controlled, cross-over study. J Clin Biochem Nutr. 2009;45(2):248–253. doi: 10.3164/jcbn.09-24. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
38. Algattas H, Kimmell KT, Vates GE. Risk of reoperation for hemorrhage in patients after craniotomy. World Neurosurg. 2016;87:531–539. doi: 10.1016/j.wneu.2015.09.020. [PubMed] [CrossRef] [Google Scholar]
39. Tirelli G, Del Piero GC, Perrino F. Ultracision harmonic scalpel in oral and oropharyngeal cancer resection. J Craniomaxillofac Surg. 2014;42(5):544–547. doi: 10.1016/j.jcms.2013.07.024. [PubMed] [CrossRef] [Google Scholar]
40. Marra A, Violati M, Broggio F, Codecà C, Blasi M, Luciani A, Zonato S, Rabbiosi D, Moneghini L, Saibene A, et al. Long-term disease-free survival in surgically-resected oral tongue cancer: a 10-year retrospective study. Acta Otorhinolaryngol Italica. 2019;39(2):84–91. doi: 10.14639/0392-100X-2336. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
41. Hussain R, Jamshed A, Iqbal H, Usman S, Irfan M, Hafeez Bhatti AB. Long term survival and impact of various prognostic factors in T1, T2 oral tongue cancer in Pakistan. J Pak Med Assoc. 2016;66(2):187–193. [PubMed] [Google Scholar]

Articles from BMC Oral Health are provided here courtesy of BMC

  NODES
INTERN 2
Note 3
twitter 2